Initial inhaler choice in COPD: real-world evidence

Initial inhaler choice in COPD: real-world evidence

Bibliographic Details
Main Author:	Thomas Jones
Format:	Article
Language:	English
Published:	European Respiratory Society 2019-12-01
Series:	Breathe
Online Access:	http://breathe.ersjournals.com/content/15/4/350.full

Similar Items

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
by: Vestbo J, et al.
Published: (2019-04-01)

The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients
by: Darbà J, et al.
Published: (2015-10-01)

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts
by: Se Hee Lee, et al.
Published: (2019-03-01)

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD
by: Kardos P, et al.
Published: (2016-11-01)

Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study
by: Wei Cheng, et al.
Published: (2021-09-01)

Inhaler treatment options in COPD
by: S. P. Newman
Published: (2005-12-01)

Inhalation devices in COPD Management
by: Romaniuk Verge, Kathy
Published: (2011)

Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study
by: Sicras-Mainar A, et al.
Published: (2020-12-01)

Exacerbations in COPD patients treated with Inhaled Corticosteroids/Long-acting β2 agonists combinations, switching to another combination drugs or inhaler device: A “real – world” study
by: Diego Sangiorgi, et al.
Published: (2017-01-01)

Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD
by: Albertson TE, et al.
Published: (2019-06-01)

Inhaled therapy reduces COPD mortality
by: Stefan Andreas, et al.
Published: (2020-11-01)

Improving adherence with inhaler therapy in COPD
by: Suzanne C Lareau, et al.
Published: (2010-11-01)

Single Inhaler LABA/LAMA for COPD
by: Mario Malerba, et al.
Published: (2019-04-01)

Safety and tolerability of inhalational anticholinergics in COPD
by: Sharafkhaneh A, et al.
Published: (2013-03-01)

COPD: misuse of inhaler devices in clinical practice
by: Duarte-de-Araújo A, et al.
Published: (2019-05-01)

Evaluating inhaler use technique in COPD patients
by: Pothirat C, et al.
Published: (2015-07-01)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
by: Jose R. Jardim, et al.
Published: (2019-04-01)

Pharmacist involvement in the inhaler choice improves lung function in patients with COPD: a prospective single-arm study
by: Eiji Shiwaku, et al.
Published: (2021-08-01)

Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey
by: Price D, et al.
Published: (2018-02-01)

“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD
by: Vogelmeier C, et al.
Published: (2017-02-01)

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
by: Bourbeau J, et al.
Published: (2021-03-01)

Inhaler choice in primary practice
by: K. R. Chapman, et al.
Published: (2005-12-01)

Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey [Erratum]
by: Price D, et al.
Published: (2018-07-01)

Prevalence and clinical features of asthma-COPD overlap in patients with COPD not using inhaled corticosteroids
by: Kuniaki Hirai, et al.
Published: (2021-01-01)

The Effects of Inhaled Steroid and Theophylline on Systemic Inflammation in Copd
by: H. Boyaci, et al.
Published: (2011-09-01)

COPD: understanding patients’ adherence to inhaled medications
by: Duarte-de-Araújo A, et al.
Published: (2018-09-01)

Improving inhaler use in COPD and the role of patient preference
by: E. D. Bateman
Published: (2005-12-01)

Opinion of pneumologists on the importance of inhalers in patients with asthma or COPD
by: Mitja Košnik, et al.
Published: (2017-04-01)

Current appraisal of single inhaler triple therapy in COPD
by: Lipworth B, et al.
Published: (2018-09-01)

Inhaled treatment of COPD: a Delphi consensus statement
by: Ninane V, et al.
Published: (2017-03-01)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
by: Avdeev S, et al.
Published: (2019-06-01)

Choosing the right inhaler for your asthma or COPD patient
by: Usmani OS
Published: (2019-03-01)

Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis
by: Peng Y, et al.
Published: (2021-09-01)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
by: Cheng S, et al.
Published: (2017-07-01)

In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy
by: Ciciliani A, et al.
Published: (2017-05-01)

Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial
by: Claudia Gregoriano, et al.
Published: (2018-12-01)

From large clinical trials to management of COPD in the real world
by: Mario Cazzola
Published: (2009-02-01)

Inhaled Formoterol-Fluticasone Single Inhaler Therapy in Asthma: Real-World Efficacy, Budget Impact, and Potential to Improve Adherence
by: V. Rajesh, et al.
Published: (2020-01-01)

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD
by: Ming SWY, et al.
Published: (2020-11-01)

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes
by: Bosnic-Anticevich S, et al.
Published: (2016-12-01)